Logo-bi
Original Research
Masumeh Zamanlu, Morteza Eskandani*, Reza Mohammadian, Nazila Entekhabi, Mohammad Rafi, Mehdi Farhoudi*
Bioimpacts. 2018;8(1): 31-38. doi: 10.15171/bi.2018.05
PMCID: PMC5915706     PMID: 29713600     Scopus ID: 85044265885    
Original Research
Cécilia Delattre*, Diego Velazquez, Caroline Roques, Graciela Pavon-Djavid, Véronique Ollivier, Anna Lokajczyk, Thierry Avramoglou, Virginie Gueguen, Liliane Louedec, Giuseppina Caligiuri, Martine Jandrot-Perrus, Catherine Boisson-Vidal, Didier Letourneur, Anne Meddahi-Pelle
Bioimpacts. 2019;9(1): 25-36. doi: 10.15171/bi.2019.04
PMCID: PMC6378099     PMID: 30788257     Scopus ID: 85060479725    
Schematic illustration of the subsequent steps for the stents coating process and the evaluation of their biocompatibility: in vitro, ex vivo and in vivo (abdominal aorta stenting and stent restenosis preclinical models) evaluation of Dex-PBMA.
Original Research
Maryam Asariha ORCID, Azam Chahrdoli, Farshad Qalekhani, Mahnaz Ghowsi, Mehdi Fouladi, Maryam Gholamhosseinpour, Ali Fattahi* ORCID
Bioimpacts. 2020;10(4): 217-226. doi: 10.34172/bi.2020.28
PMCID: PMC7502908     PMID: 32983937     Scopus ID: 85092035841    
In this study biocompatible gold nanoparticles (GNPs) were synthesized using chondroitin sulfate (CHS) as reducing and capping materials. CHS-GNPs were characterized (UV, XRD-FTIR and TEM) and their biological (antibacterial, antioxidant and cytotoxicity effects and blood compatibility) and electrochemical properties were evaluated.
Review
Clarence S Yah* ORCID, Geoffrey S. Simate
Bioimpacts. 2020;10(3): 195-203. doi: 10.34172/bi.2020.24
PMCID: PMC7416007     PMID: 32793442     Scopus ID: 85089711934    
The impact of bio-nanomaterials XCELLigence-cytotoxicity testing. A non-invasive in-vitro monitoring process that mimics exact continuous cellular bio-responses. However, to expand and affirm consumer safety concerns of bio-nanomaterials, additional XCELLigence data is required for bio-nanomaterials toxicity protocols and methodological development.
Original Research
Marjan Bahraminasab* ORCID, Samaneh Arab, Somaye Ghaffari
BioImpacts. 2022;12(3): 247-259. doi: 10.34172/bi.2021.2330
PMCID: PMC9124877     PMID: 35677667     Scopus ID: 85132130879    
Our in-vitro findings demonstrated that the 75Ti, 50Ti, and 25Ti composites havehigh potential to be used as load-bearing orthopedic materials.
Original Research
Mohammadreza Dastouri* ORCID, Hilal Ozdag ORCID, Ahmet Ruchan Akar ORCID, Alp Can ORCID
Bioimpacts. 2023;13(4): 289-300. doi: 10.34172/bi.2022.24132
PMCID: PMC10460769     PMID: 37645025     Scopus ID: 85168143106    
In this study, we demonstrate a multi-step differential differentiation of iPS cells into EPCs and VSMCs, unlike previous studies in which iPS cells have been induced to differentiate into ECs. Concomitantly, during the differentiation protocol, Myc and Klf4 oncogene expressions were also analyzed from a translational perspective.
Original Article
Jalil Mirzazadeh ORCID, Mir Reza Majidi* ORCID, Parviz Norouzi*, Reza Faridi-Majidi, Karim Asadpour-Zeynali
Bioimpacts. 2024;14(3): 28854. doi: 10.34172/bi.2023.28854
PMCID: PMC11199931     PMID: 38938755     Scopus ID: 85179448072    
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge